Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Abbott

Abbott Labs Stock Rises As Medical Devices Drive Quarterly Beat

Abbott stock edged higher Wednesday after the health care giant narrowly beat Wall Street's third-quarter expectations.

Investors Business Daily

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Investors Business Daily

Abbott's Quarterly Earnings Preview: What You Need to Know

Abbott is all set to release its third-quarter earnings later this month, and analysts expect a single-digit profit increase.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

'Virus Hunters' Track Threats To Head Off Next Pandemic

A global network of doctors and laboratories is working to pinpoint emerging viral threats, including many driven by climate change, in a bid to head off the world's next pandemic.

International Business Times

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

3 MedTech Stocks Revolutionizing Healthcare

MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…

StockNews.com

How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom

Abbott Laboratories launched its newest CGM in the U.S. on Thursday. The biosensor named Lingo is the first-ever for people without diabetes.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

3 Recession-Proof Dividend Kings to Buy For a Lifetime of Income

Discover three proven, quality companies you can own to get through a looming recession.

Barchart

Is Abbott Stock Underperforming the S&P 500?

Abbott's shares have underperformed the broader S&P 500 this year, but analysts are highly bullish on the stock's potential.

Barchart

3 Robotics Stocks to Watch for the Automation Revolution

The robotics industry’s long-term growth is fueled by rapid technological advancements and automation across several sectors. Thus, it could be wise to keep an eye on fundamentally solid robotics stocks Stryker (SYK), Honeywell International (HON), and Medtronic (MDT) to capitalize on the automation revolution. Keep reading….

StockNews.com

3 Stocks Benefiting From the AI Boom—but Not Tech Companies

Artificial intelligence (AI) has been creating ripple effects across non-tech industries with new avenues for growth and innovation. With that in mind, let’s not miss out on investing in quality stocks from different sectors: Costco Wholesale Corp. (COST), Medtronic (MDT), and Korn Ferry (KFY), which are capitalizing on the AI…

StockNews.com

3 Dividend Kings With Massive Dividend Growth Rates

Learn how these three dividend kings can boost your portfolio's income potential.

Barchart

Nervous About the Market? 3 Defensive Stock Picks to Consider This August

Explore three defensive stock picks from the consumer staples, healthcare, and utilities sectors that offer stability amid market uncertainty in August.

Barchart

Lawsuits Filed Against Abbott Nutrition Over Infant Formula Contamination

Lawsuit filed against Abbott Nutrition over tainted infant formula linked to baby's death, raising awareness about powdered formula risks.

Top News

Abbott Warns Of Potential Inaccuracies In Blood Sugar Monitoring Sensors

Abbott issues warning about potential inaccuracies in FreeStyle Libre 3 blood sugar sensors, offering free replacements for affected devices.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Abbott warns that some of its blood sugar monitors may need replacement due to incorrect readings

Abbott is warning that sensors on some of its blood sugar monitoring systems may need to be replaced to prevent inaccurate readings

Barchart

3 Highest-yielding Dividend Aristocrats With Strong-buy Ratings

Discover the top three highest-rated, highest-yielding Dividend Aristocrats for your retirement portfolio.

Investors Business Daily

Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review

The stock market rally had some wild moves during the week. The Dow Jones and Russell 2000 jumped, but came off highs. The Nasdaq tumbled.

Investors Business Daily

Abbott Makes A Bearish Move Despite 'Clean Print' That Includes A Guidance Boost

Abbott stock slumped Thursday despite offering a "clean print" that includes strong growth for its diabetes business and a guidance boost.

Barchart

Abbott's Q2 2024 Earnings: What to Expect

Abbott is poised to release its second-quarter results this month, and analysts are projecting a slight increase in profits.

StockNews.com

3 Top S&P 500 Stocks With Strong Analyst Ratings

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

The Independent UK

FDA took months to react to complaint about Abbott infant formula factory, audit finds

The U.S. Food and Drug Administration took 15 months to act on a whistleblower complaint about the Abbott Nutrition factory at the center 2022's nationwide infant formula shortage

1 2 3 4 5

People

Donald Trump

110,536 stories

Margaret Kaczor Andrew

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.